Diurnal pattern of rat pancreatic acinar cell replication.
Fully differentiated pancreatic acinar cells can enter the cell cycle under appropriate conditions in the rat. The aim of this study was to analyse the diurnal pattern of acinar cell proliferation as a function of food intake and the release of cholecystokinin (CCK), because the peptide hormone CCK is a major physiological regulator of rat pancreatic acinar cell replication. Pancreatic acinar cell replication was quantitated using an antibody against the S-phase marker proliferating cell nuclear antigen (PCNA). In addition, acinar cells in S-phase were detected after injecting bromodeoxyuridine (BrdU) and subsequent immunohistochemical staining of BrdU-positive nuclei. Rat pancreata were analysed during the day under standard diet conditions, as well as after various schedules of fasting and refeeding and after the application of the CCK receptor antagonist L-364,718. Between 6 a.m. and 6 p.m., the PCNA labeling index was 4.4+/-0.9%, while between 9 p.m. and 3 a.m. the PCNA labeling index was elevated and reached peak values of 11.4% (mean value: 7.8+/-2.5%) around midnight. BrdU-positive cells also doubled around midnight, compared to the 9:00 a.m. value. In fasted rats, acinar cell proliferation was completely suppressed and this suppression could be overcome by injection of the CCK analog cerulein. In addition, the CCK antagonist L-364,718 led to the same results as fasting. Here we show for the first time that there is a diurnal pattern of pancreatic acinar cell proliferation in rats, which is dependent on food intake and is mediated by CCK.
Biederbick
A
A
University of Marburg, Department of Cytobiology and Cytopathology, Robert-Koch-Strasse 5, D-35033 Marburg, Germany.
Elsässer
H
H
D000818:Animals; D001570:Benzodiazepinones / Q000494:pharmacology; D002454:Cell Differentiation; D002455:Cell Division; D002108:Ceruletide / Q000494:pharmacology; D002766:Cholecystokinin / Q000378:metabolism / Q000502:physiology*; D002940:Circadian Rhythm; D004261:DNA Replication; D020109:Devazepide; D004435:Eating / Q000502:physiology; D005215:Fasting / Q000502:physiology; D008297:Male; D010179:Pancreas / Q000166:cytology* / Q000187:drug effects; D018809:Proliferating Cell Nuclear Antigen / Q000032:analysis; D051381:Rats; D017208:Rats, Wistar; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors
D001570:Benzodiazepinones; D018809:Proliferating Cell Nuclear Antigen; D011949:Receptors, Cholecystokinin; D002108:Ceruletide; D002766:Cholecystokinin; D020109:Devazepide